drugset / Trial / NCT02740166

Preventing Recurrent Bleeding After Eradication of Esophageal Varices

NCT02740166

Phase 4 Unknown 212 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupOpen-labelTreatment

Summary

Esophageal variceal bleeding is a severe complication of portal hypertension. Banding ligation plus non-selective beta-blockers is the current recommendation for prevention of recurrent bleeding. However, the optimal duration of use of non-selective beta-blockers is not well defined. This study aims at comparing the rebleeding rate and adverse effects in patients using or without using propranolol after eradication of esophageal varices.

Timeline

Start
2013-06
Primary completion
2018-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 30 mg

Indications